ReviewJournal of breast imaging
BI-RADS 3 on Screening Breast Ultrasound: What Is It and What Is the Appropriate Management?
Review in Journal of breast imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study.Breast cancer (Tokyo, Japan) · 2026Observational
- Training AI to Improve Distinction of Triple-Negative Invasive Breast Cancer from Cysts and Fibroadenomas on Ultrasound.Diagnostics (Basel, Switzerland) · 2026Article
- The role of combined ultrasonic BI-RADS and ultrasound elastography in discriminating between benign and malignant breast nodules.Medicine · 2026Article
- Supplemental automated breast ultrasound in negative screening mammography: early-stage cancer detection in dense breasts with limited yield in non-dense breasts.Ultrasonography (Seoul, Korea) · 2026Article
- Over-detection and over-surveillance in breast screening: current status and the potential for artificial intelligence optimisation.Insights into imaging · 2025Review
- Why don't all women with extremely dense breasts want MRI screening?European radiology · 2024Article
- Validating racial and ethnic non-bias of artificial intelligence decision support for diagnostic breast ultrasound evaluation.Journal of medical imaging (Bellingham, Wash.) · 2023Article
- Evaluation of Two-Year Follow-Up of Patients with BI-RADS 3 Breast Ultrasound Lesions in a Single Private Ultrasound Study.Advanced biomedical research · 2023Article
- Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.Cancer science · 2022Article
Corrections and comments
- Commented on by
Authors and funding
1 author.
Funding
Abstract
US is widely used in breast imaging for diagnostic purposes and is also used increasingly for supplemental screening in women with dense breasts. US frequently depicts masses that are occult on mammography, even after tomosynthesis, and the vast majority of such masses are benign. Many masses seen only on screening US are easily recognized as benign simple cysts. Probably benign, BI-RADS 3, or low suspicion, BI-RADS 4A masses are also common and often prompt short-interval follow-up or biopsy, respectively, yet the vast majority of these are benign. This review details appropriate characterization, classification, and new approaches to the management of probably benign masses seen on screening US that can reduce false positives and, thereby, reduce costs and patient anxiety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.